Demo Sign up Log In

Tg Therapeutics Inc (TGTX)

Operating Expenses

$522.21M

TTM · Period ending: Jun 30, 2026 · USD

TGTX Operating Expenses

Latest reported$522.21Mperiod endingJun 30, 2026

Latest reported$522.21Mperiod endingJun 30, 2026

TGTX Operating Expenses ($3.90M → $522.21M)

Annual operating expenses

High-resolution chart · PNG

TGTX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2025	392,249,000
Dec 31, 2024	248,589,000
Dec 31, 2023	198,898,000
Dec 31, 2022	220,836,000
Dec 31, 2021	350,669,000
Dec 31, 2020	273,746,000
Dec 31, 2019	169,207,000
Dec 31, 2018	174,552,000
Dec 31, 2017	118,864,132
Dec 31, 2016	79,121,509
Dec 31, 2015	63,332,397
Dec 31, 2014	55,873,473
Dec 31, 2013	20,320,770
Dec 31, 2012	25,809,447
Dec 31, 2011	881,974
Dec 31, 2010	2,016,735
Dec 31, 2009	1,771,558
Dec 31, 2008	4,412,702
Dec 31, 2007	12,143,957
Dec 31, 2006	10,000,327
Dec 31, 2005	19,357,005
Dec 31, 2004	6,142,823
Dec 31, 2003	4,758,353
Dec 31, 2002	2,052,915
Dec 31, 2001	3,736,734
Dec 31, 2000	4,462,103
Dec 31, 1999	3,100,000
Dec 31, 1998	5,900,000
Dec 31, 1997	5,500,000
Dec 31, 1996	3,900,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.